HIV-1 integrase inhibitors: a review of their chemical development.
about
Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutationsNew in silico and conventional in vitro approaches to advance HIV drug discovery and design.Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replicationIdentification of a novel type of small molecule inhibitor against HIV-1.From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine.Quinolines from the cyclocondensation of isatoic anhydride with ethyl acetoacetate: preparation of ethyl 4-hydroxy-2-methylquinoline-3-carboxylate and derivatives
P2860
HIV-1 integrase inhibitors: a review of their chemical development.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
HIV-1 integrase inhibitors: a review of their chemical development.
@en
HIV-1 integrase inhibitors: a review of their chemical development.
@nl
type
label
HIV-1 integrase inhibitors: a review of their chemical development.
@en
HIV-1 integrase inhibitors: a review of their chemical development.
@nl
prefLabel
HIV-1 integrase inhibitors: a review of their chemical development.
@en
HIV-1 integrase inhibitors: a review of their chemical development.
@nl
P2860
P356
P1476
HIV-1 integrase inhibitors: a review of their chemical development
@en
P2093
Kundan B Ingale
P2860
P304
P356
10.3851/IMP1740
P577
2011-11-17T00:00:00Z